TCL Archive FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one. September 16, 2005
TCL Archive NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial November 26, 2010
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive In Brief: BMS Oncology Names New VP, Marketing; Hortobagyi Wins Freyer Medal; Prerez Honored October 24, 1997
TCL Archive Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma July 25, 2014
